The Journal of Organic Chemistry
Note
1,3,6-Triphenylfulvene 6.15 Benzaldehyde (1.88 mL, 15.6
mmol), pyrrolidine (1.75 mL, 21.3 mmol), and 1,3-diphenylcyclo-
pentadiene (3.1 g, 14.2 mmol) were used employing the procedure
outlined for the preparation of 1,3-diphenyl-6-(tert-butyl)fulvene 4 to
obtain 6 as a cherry-red, microcrystalline solid (1.89 g, 65%). Crystals
suitable for single-crystal X-ray diffraction were obtained from 50:50
C6H6/MeOH at −5 °C. Mp: 121−22 °C. 1H NMR (300 MHz,
CDCl3): δ 7.26−7.74 (overlapping m, 16H, Ph, and fulvene exocyclic
CH-Ph), 7.00, 7.04 (2H, fulvene ring-CH). 13C NMR (75 MHz,
CDCl3): δ 114.6, 126.1, 127.1, 128.0, 128.1, 128.4, 128.6, 128.7, 129.1,
129.4, 131.0, 135.2, 136.0, 137.1, 138.5, 141.6, 144.3, 146.8 (CH and
C). HRMS-EI: m/z calcd for C24H18 [M]+, 306.14085; found,
306.14108.
butyl)fulvene 4 to obtain 11 as a black microcrystalline solid (1.45 g,
71%). Dark-red prismatic crystals of 11, suitable for single-crystal X-ray
diffraction, were obtained from THF layered with MeCN. Mp: 195−
1
196 °C. H NMR (300 MHz, CDCl3): δ 7.26−8.36 (overlapping m,
20H, Ph, fulvene exocyclic CH-pyrene, and pyrene CH), 7.11, 6.99
(2H, fulvene ring-CH). Selected 13C NMR (75 MHz, CDCl3): δ
115.8, 123.8, 124.7, 125.7, 125.8, 126.1, 126.2, 127.1, 127.4, 128.0,
128.25, 128.33, 128.34, 128.4, 128.6, 128.7, 129.4, 129.5, 130.1, 130.9,
131.3, 131.4, 131.9, 135.2, 136.1, 136.5, 141.1, 146.0, 146.9. HRMS-EI:
m/z calcd for C34H22 [M]+, 430.17215; found, 430.17145.
1,3-Diphenyl-6-(2-fluorenyl)fulvene 12. 2-Fluorenecarboxalde-
hyde (2.95 g, 15.2 mmol), pyrrolidine (1.71 mL, 20.9 mmol), and 1,3-
diphenylcyclopentadiene (3.01 g, 13.9 mmol) were used employing
the procedure outlined for the preparation of 1,3-diphenyl-6-(tert-
butyl)fulvene 4 to obtain 12 as a dark red−brown microcrystalline
solid (5.48 g, 93%). Mp: 179−180 °C. 1H NMR (300 MHz, CDCl3):
δ 7.30−7.88 (overlapping m, 18H, Ph, fulvene exocyclic CH-fluorene,
and fluorene CH), 7.00, 7.13 (2H, fulvene ring-CH), 3.98 (s, 2H,
CH2). 13C NMR (75 MHz, CDCl3): δ 36.9 (CH2), 114.6, 120.1,
120.4, 125.2, 126.1, 126.9, 127.0, 127.3, 127.4, 127.7, 127.9, 128.4,
128.7, 129.4, 130.1, 135.4, 135.7, 136.2, 139.2, 141.0, 141.8, 142.9,
143.6, 143.7, 143.9, 146.6 (CH and C). HRMS-EI m/z calcd for
C31H22 [M]+, 394.17215; found, 394.17395.
1,3-Diphenyl-6-(4-trifluoromethylphenyl)fulvene 7. 4-
(Trifluoromethyl)benzaldehyde (3.40 mL, 25.7 mmol), pyrrolidine
(2.30 mL, 27.5 mmol), and 1,3-diphenylcyclopentadiene (4.00 g, 18.3
mmol) were used employing the procedure outlined for the
preparation of 1,3-diphenyl-6-(tert-butyl)fulvene 4 to obtain 7 as a
1
maroon microcrystalline solid (2.60 g, 38%). Mp: 115−116 °C. H
NMR (300 MHz, CDCl3): δ 7.22−7.74 [overlapping m, 15H, Ph,
fulvene exocyclic CH-(p-(CF3)Ph, and p-(CF3)Ph CH], 7.02, 6.93
(2H, fulvene ring-CH). 13C NMR (75 MHz, CDCl3): δ 125.6 (q, CF3,
JCF = 3.9 Hz), 113.9, 126.2, 127.3, 128.3, 128.5, 128.8, 128.9, 129.4,
130.6, 134.8, 135.6, 135.9, 140.5, 141.6, 146.3, 147.8 (CH and C). 19
F
NMR (376 MHz, CDCl3): δ −62.6 (CF3). HRMS-EI: m/z calcd for
ASSOCIATED CONTENT
* Supporting Information
■
C25H17F3 [M]+, 374.12824; found, 374.12882.
S
1,3-Diphenyl-6-(3,5-dimethoxyphenyl)fulvene 8. 3,5-Dime-
thoxybenzaldehyde (1.88 mL, 15.6 mmol), pyrrolidine (1.75 mL,
21.3 mmol), and 1,3-diphenylcyclopentadiene (3.1 g, 14.2 mmol) were
used employing the procedure outlined for the preparation of 1,3-
diphenyl-6-(tert-butyl)fulvene 4 to obtain 8 as a dark red solid (2.79 g,
63%). Dark-red prismatic crystals suitable for single-crystal X-ray
diffraction were obtained by cooling (−5 °C) a concentrated solution
Figure of electronic absorption spectra and figures depicting
1H, 13C, and 19F NMR spectra, text describing crystallographic
details, tables of crystallographic data and cifs for fulvenes 4−6,
8, and 11, and text and data related to DFT calculations. This
material is available free of charge via the Internet at http://
1
of 8 in CH2Cl2. Mp: 124−125 °C. H NMR (300 MHz, CDCl3): δ
3.84 (s, 6H, OMe), 6.51 (t, 1H, MeOCCHCOMe), 6.77 (d, 2H,
MeOCCHCCHCOMe), 6.99, 7.04 (2H, fulvene ring-CH), 7.18−7.74
[overlapping m, 11H, Ph, and fulvene exocyclic CH-(3,5-dimethox-
yphenyl)]. 13C NMR (75 MHz, CDCl3): δ 55.4 (OMe), 101.4, 108.4,
114.6, 126.1, 127.0, 128.0, 128.2, 128.4, 128.7, 129.4, 135.1, 135.9,
138.4, 138.8, 141.6, 144.6, 146.7, 160.8 (CH and C). HRMS-EI: m/z
calcd for C26H22O2 [M]+, 366.16198; found, 366.16105.
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
1,3-Diphenyl-6-(3-phenoxyphenyl)fulvene 9. 3-Phenoxyben-
zaldehyde (1.09 g, 5.51 mmol), pyrrolidine (0.57 mL, 6.89 mmol), and
1,3-diphenylcyclopentadiene (1.03 g, 4.59 mmol) were used employ-
ing the procedure outlined for the preparation of 1,3-diphenyl-6-(tert-
butyl)fulvene 4 to obtain 9 as a dark-red microcrystalline solid (1.59 g,
ACKNOWLEDGMENTS
■
We dedicate this paper to Professor John S. Wilkes who
recently retired from his position as Director, Chemistry
Research Center, USAF Academy. John is a renowned ionic-
liquids chemist and will be deeply missed. It has been a great
experience working with him over the years. We acknowledge
the Air Force Office of Scientific Research and the Department
of Chemistry, USAF Academy, for funding.
1
87%). Mp: 132−133 °C. H NMR (300 MHz, CDCl3): δ 7.02−7.68
[overlapping m, 20H, Ph, fulvene exocyclic CH-(3-phenoxyphenyl),
and 3-phenoxyphenyl CH], 6.97, 6.93 (2H, fulvene ring-CH). 13C
NMR (75 MHz, CDCl3): δ 114.3, 119.3, 120.1, 123.7, 125.5, 126.1,
127.1, 128.0, 128.2, 128.4, 128.6, 129.3, 129.9, 130.0, 135.0, 135.8,
137.5, 138.6, 141.6, 144.7, 146.9, 156.8, 157.8 (CH, CO and C).
HRMS-EI: m/z calcd for C30H22O [M]+, 398.16707; found,
398.16659.
REFERENCES
■
(1) Hong, B.; Chen, F.; Chen, S.; Kiao, J.; Lee, G. Org. Lett. 2005, 7,
557 and references therein.
(2) Strohfeldt, K.; Tacke, M. Chem. Soc. Rev. 2008, 37, 1174.
(3) Vicente, J.; Abad, J.; Gil-Rubio, J. Organometallics 1995, 14, 2677.
(4) Hafner, K. Pure Appl. Chem. 1990, 62, 531 and references
therein.
(5) Erden, I.; Xu, F.; Sadoun, A.; Smith, W.; Sheff, G.; Ossun, M. J.
Org. Chem. 1995, 60, 813.
(6) For leading references in the literature, see: Enk, B.; Kopacka,
H.; Wurst, K.; Muller, T.; Bildstein, B. Organometallics 2009, 28, 5575.
(7) Aqad, E.; Leriche, P.; Mabon, G.; Gorgues, A.; Khodorkovsky, V.
Org. Lett. 2001, 3, 2329.
(8) Andrew, T. L.; Cox, J. R.; Swager, T. M. Org. Lett. 2010, 12, 5302.
(9) Kondo, K.; Goda, H.; Takemoto, K.; Aso, H.; Sasaki, T.;
Kawakami, K.; Yoshida, H.; Yoshida, J. J. Mater. Chem. 1992, 2, 1097.
(10) Dong, Y.; Geng, Y.; Ma, J.; Huang, R. Organometallics 2006, 25,
447 and referenes therein.
1,3-Diphenyl-6-[5-(2,2′-bithiophene)]fulvene 10. (2,2′-Bithio-
phene)-5-carboxaldehyde (4.90 g, 25.7 mmol), pyrrolidine (2.30 mL,
27.5 mmol), and 1,3-diphenylcyclopentadiene (4.00 g, 18.3 mmol)
were used employing the procedure outlined for the preparation of
1,3-diphenyl-6-(tert-butyl)fulvene 4 to obtain 10 as a dark red−brown
microcrystalline solid (5.20 g, 72%). Mp: 130−134 °C. 1H NMR (300
MHz, CDCl3): δ 6.90−7.80 (overlapping m, 18H, Ph, fulvene ring-
CH, fulvene exocyclic CH-bithiophene and bithiophene CH). 13C
NMR (75 MHz, CDCl3): δ 113.3, 124.1, 124.8, 125.7, 126.2, 127.0,
127.3, 127.9, 128.1, 128.4, 128.7, 129.3, 130.0, 135.0, 135.3, 136.1,
136.8, 139.5, 141.0, 142.0, 143.0, 146.4. HRMS-EI: m/z calcd for
C26H18S2 [M]+, 394.08500; found, 394.08411.
1,3-Diphenyl-6-(1-pyrene)fulvene 11. 1-Pyrenecarboxaldehyde
(1.30 g, 5.51 mmol), pyrrolidine (0.57 mL, 6.89 mmol), and 1,3-
diphenylcyclopentadiene (1.03 g, 4.59 mmol) were used employing
the procedure outlined for the preparation of 1,3-diphenyl-6-(tert-
E
dx.doi.org/10.1021/jo301101x | J. Org. Chem. XXXX, XXX, XXX−XXX